MAIA Biotechnology Inc (MAIA)
3.28
+0.13
(+4.13%)
USD |
NYAM |
May 03, 16:00
3.22
-0.06
(-1.83%)
After-Hours: 20:00
MAIA Biotechnology Price to Book Value: 141.37 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 141.37 |
| May 02, 2024 | 135.77 |
| May 01, 2024 | 125.86 |
| April 30, 2024 | 126.29 |
| April 29, 2024 | 138.36 |
| April 26, 2024 | 126.72 |
| April 25, 2024 | 115.51 |
| April 24, 2024 | 115.94 |
| April 23, 2024 | 106.03 |
| April 22, 2024 | 97.41 |
| April 19, 2024 | 92.67 |
| April 18, 2024 | 84.48 |
| April 17, 2024 | 85.34 |
| April 16, 2024 | 88.79 |
| April 15, 2024 | 87.93 |
| April 12, 2024 | 95.04 |
| April 11, 2024 | 104.74 |
| April 10, 2024 | 106.03 |
| April 09, 2024 | 110.77 |
| April 08, 2024 | 107.32 |
| April 05, 2024 | 101.29 |
| April 04, 2024 | 94.82 |
| April 03, 2024 | 100.00 |
| April 02, 2024 | 101.29 |
| April 01, 2024 | 106.89 |
| Date | Value |
|---|---|
| March 28, 2024 | 94.82 |
| March 27, 2024 | 103.89 |
| March 26, 2024 | 102.21 |
| March 25, 2024 | 106.82 |
| March 22, 2024 | 88.39 |
| March 21, 2024 | 81.27 |
| March 20, 2024 | 67.32 |
| March 19, 2024 | 68.95 |
| March 18, 2024 | 61.20 |
| March 15, 2024 | 56.71 |
| March 14, 2024 | 53.45 |
| March 13, 2024 | 47.67 |
| March 12, 2024 | 46.60 |
| March 11, 2024 | 46.17 |
| March 08, 2024 | 47.31 |
| March 07, 2024 | 49.80 |
| March 06, 2024 | 52.29 |
| March 05, 2024 | 52.65 |
| March 04, 2024 | 51.58 |
| March 01, 2024 | 49.62 |
| February 29, 2024 | 46.60 |
| February 28, 2024 | 49.09 |
| February 27, 2024 | 48.38 |
| February 26, 2024 | 48.73 |
| February 23, 2024 | 49.09 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.753
Minimum
Oct 20 2022
141.37
Maximum
May 03 2024
18.27
Average
6.091
Median
Feb 03 2023
Price to Book Value Benchmarks
| Cyclacel Pharmaceuticals Inc | 4.344 |
| Avid Bioservices Inc | 2.907 |
| Oragenics Inc | 3.043 |
| NeuBase Therapeutics Inc | 0.1653 |
| Viking Therapeutics Inc | 9.088 |
Price to Book Value Related Metrics
| Price | 3.28 |
| Earnings Yield | -45.73% |
| Market Cap | 67.51M |